comparemela.com
  1. Home
  2. Live Updates
  3. MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Chlorine-Induced Acute Respiratory Distress Syndrome : comparemela.com

MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Chlorine-Induced Acute Respiratory Distress Syndrome

MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Chlorine-Induced Acute Respiratory Distress Syndrome

marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Tokyo ,Japan ,Kazuko Matsuda ,Davidh Crean ,Trademark Office ,Exchange Commission ,Nasdaq ,Medicinova Inc ,Standard Market ,Tokyo Stock Exchange ,Code Number ,Chief Medical Officer ,Private Securities Litigation Reform Act ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.